AGS 2024: Tips for implementing telehealth into ophthalmology
March 1st 2024April Maa, MD, sat down with David Hutton of Ophthalmology Times to discuss her presentation at the annual American Glaucoma Society meeting held in Huntington Beach, about tips and tricks for implementing telehealth into ophthalmology.
AGS 2024: Laser refractive surgery in high-risk glaucoma suspects
March 1st 2024Michael Greenwood, MD, discusses the safety of laser refractive surgery for patients at high risk for glaucoma, focusing on the need for thorough pre-surgery assessment, careful monitoring of eye pressure during and after the procedure, and awareness of prolonged steroid use following PRK.
AGS 2024: Travoprost intraocular implant safe and effective in phakic eyes
February 29th 2024Steven R. Sarkisian, MD, sat down with David Hutton of Ophthalmology Times to discuss his poster about the Travoprost intraocular implant in phakic eyes from the American Glaucoma Society meeting held in Huntington Beach
AGS 2024: Travoprost intraocular implant in OAG and OHT subjects
February 29th 2024I. Paul Singh, MD, sat down with David Hutton of Ophthalmology Times to discuss his poster "Travoprost Intraocular Implant Demonstrates Efficacy in Diverse Subpopulations of OAG and OHT Subjects," from the American Glaucoma Society meeting held in Huntington Beach
AGS 2024: Leon Herndon, MD, President of AGS, previews the annual meeting
February 29th 2024Leon Herndon, MD, President of the American Glaucoma Society, sat down with David Hutton of Ophthalmology Times to discuss the AGS meeting held in Huntington Beach and what attendees can expect as well as new and exciting information to come from the meeting.
EnVision Summit 2024: Tips to launch a personal IPO journey for women in eye care
February 16th 2024Marsha Link, PhD, uses three words—Imagine, Prepare, and Optimize—to encourage women to assess their current leadership journey, strategically plan for advancement, and explore new opportunities for growth and impact in vision care.
Kathryn A. Colby, MD, PhD, looks to the future in ophthalmology and at NYU
February 16th 2024David Hutton of Ophthalmology Times talks with Kathryn A. Colby, MD, PhD, Elisabeth J. Cohen Professor and Chair, NYU Langone Department of Ophthalmology, about the year the department had in 2023 as well as an outlook at advancements in the field of ophthalmology moving forward.
Kiora Pharmaceuticals CEO discusses partnership with Théa Open Innovation and pipeline updates
February 12th 2024David Hutton of Ophthalmology Times talks with Brian Strem, PhD, CEO Kiora Pharmaceuticals, about their recent partnership with Théa Open Innovation and further development of their KIO-301 and KOI-104 programs.
Angiogenesis 2024: AVD-104 for Geographic Atrophy
February 3rd 2024Carl Danzig, MD, sat down with Martin David Harp of Ophthalmology Times to discuss his presentation AVD-104 for Geographic Atrophy: Glyco-immunologic modulation of macrophage activity from the Angiogenesis Exudation and Degeneration 2024 event.
Angiogenesis 2024: Precursor lesions for development of atrophy and AMD
February 3rd 2024SriniVas R. Sadda, MD, sat down with David Hutton of Ophthalmology Times to discuss his presentation about precursor lesions for development of atrophy and AMD from the Angiogenesis Exudation and Degeneration 2024 event.
President and CEO of Ashvattha Therapeutics talks about the company's unique nanomedicine technology
January 28th 2024David Hutton of Ophthalmology Times talks with Jeffrey Cleland, PhD, President and CEO of Ashvattha Therapeutics, about the company's D-4517.2, a unique nanomedicine technology for the treatment of wet AMD and DME.
EnVision Summit 2024: Inside the ophthalmology track with Bonnie An Henderson, MD
January 19th 2024Bonnie An Henderson, MD, previews the EnVision Summit 2024, scheduled for February 16 to 19 in Puerto Rico, highlighting its family friendly atmosphere, diverse specialty coverage, and new sessions on leadership and health equity.
Hawaiian Eye and Retina 2024: Sizing up the impact of gene therapy in ophthalmology
January 16th 2024David A. Eichenbaum, MD, discusses the promising aspects of gene augmentation for treating common retinal diseases, addresses concerns about perpetual protein production, and considers the potential positive impact on patients by reducing treatment burdens.
Hawaiian Eye and Retina 2024: Toric IOL pearls for correcting lower levels of astigmatism
January 15th 2024David Hutton of Ophthalmology Times talks with William Trattler, MD, about his presentation "Toric IOL pearls for Correcting Lower Levels of Astigmatism" at this year's Hawaiian Eye and Retina 2024 Meeting.